Post-Transplant Lymphoproliferative Disease (PTLD)

Post-Transplant Lymphoproliferative Disease, also known as post-transplant lymphoproliferative disorder, is related to methotrexate-associated lymphoproliferative disorders and immunodeficiency-associated lymphoproliferative disease. The drugs Rituximab and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include b cells and bone marrow.